← Back to category

DiChloroAcetate: A cheap and simple cure for cancer?

Year: 2007
Device: Dichloroacetate (DCA)
Folder: diclacet
Original: Open article
Confidence
0.80
Practicability
0.60
Evidence
0.50
Fringe Score
0.40
Risk
0.30
TRL
4

Goal

Treat cancer by reactivating mitochondrial metabolism and inducing apoptosis in cancer cells

Problem

Cancer (metabolic dysregulation and uncontrolled cell growth)

Concept Summary

Dichloroacetate (DCA) is a small, inexpensive molecule that inhibits pyruvate dehydrogenase kinase, thereby re-activating mitochondrial oxidative phosphorylation in cancer cells. This metabolic shift from glycolysis to mitochondrial respiration triggers apoptosis, leading to tumor regression in vitro and in animal models while sparing normal tissue.

Principles

  • Inhibition of pyruvate dehydrogenase kinase (PDK)
  • Activation of pyruvate dehydrogenase (PDH)
  • Metabolic re-programming from glycolysis to oxidative phosphorylation
  • Induction of apoptosis in cancer cells

Scientific Domains

Biochemistry Oncology Pharmacology Molecular Biology

Materials

  • Dichloroacetate
  • Ceresine (alternative name)

Mechanisms of Action

  • DCA blocks PDK, preventing PDH inactivation
  • Restores mitochondrial function and ATP production
  • Reverses the Warburg effect in cancer cells
  • Promotes apoptotic pathways leading to cell death

Applications

  • Cancer therapy (potential monotherapy or adjunct)
  • Metabolic re-programming of tumour cells

Claimed Performance

In vitro, DCA killed lung, breast and brain cancer cells while sparing normal cells; in rat models bearing human tumour xenografts, tumours shrank dramatically after several weeks of DCA-laced water.

Experimental Evidence

Laboratory studies showed loss of immortality and death of cancer cells; animal studies reported tumour regression in rats fed DCA-containing water; results published in the journal Cancer Cell.

Replication Status

Results published in Cancer Cell; no independent replication reported in the article.

Limitations

  • No human clinical trials yet
  • Potential peripheral neuropathy at therapeutic doses
  • Lack of patent protection limiting commercial investment
  • Unclear optimal dosing and treatment schedule

Red Flags

  • Claims of a universal cure for cancer without human trial data
  • Potential over-statement of efficacy based on pre-clinical results only

Keywords

Dichloroacetate DCA Cancer metabolism Warburg effect Mitochondrial activation PDK inhibition Apoptosis

Related Technologies

Other metabolic modulators PDK inhibitors Mitochondrial targeting drugs

📷 Images

0logo.gif
0logo.gif
dca.jpg
dca.jpg
dcametab.jpg
dcametab.jpg
diclacet.jpg
diclacet.jpg